Live feed
Filing
SC 13G
SC 13G0000902664-20-000160·Quoin Pharmaceuticals, Ltd.
Schedule 13G ownership disclosure
CELLECT BIOTECHNOLOGY LTD
Security class unavailable · CUSIP: 15116C201
Event date: 2020-01-08
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 323,000
- Percent of class
- 9.9700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-20-000160
- Form type
- SC 13G
- Filer
- Quoin Pharmaceuticals, Ltd.
- CIK
- CIK 1671502
- Filed
- Jan 10, 2020
- Reporting period
- Jan 08, 2020
- Description
- Schedule 13G beneficial ownership